Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services

Contract Services

Medivation licenses anti-PD-1 immune modulatory monoclonal antibody from CureTech Medivation, and CureTech, announced Medivation has licensed exclusive worldwide rights to CureTech's late-stage clinical molecule pidilizumab (CT-011), an immune modulatory anti-PD-1 monoclonal antibody.
Contract Research & Services > Contract Services > News
Iroko inks new licensing deal with Landsteiner Scientific to market Zorvolex in Mexico By PBR Staff Writer
Iroko Pharmaceuticals has signed a licensing agreement with Landsteiner Scientific for the exclusive rights to market and sell Zorvolex (diclofenac) capsules in Mexico.
Contract Research & Services > Contract Services > News NewLink, Genentech ink licensing deal for development of NLG919 By PBR Staff Writer
US-based biopharmaceutical firm NewLink Genetics has entered into an exclusive worldwide license agreement with Genentech, a member of the Roche, to develop its IDO pathway inhibitor NLG919.
Contract Research & Services > Contract Services > News
See more Contract Services news

Latest Contract Services News and Insight

View all Contract Services news or find news targeted to your interests
Enanta Pharmaceuticals provides update on its collaboration agreement with AbbVie
Enanta Pharmaceuticals, a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, has announced that it has decided not to exercise its co-development option for ABT-493, Enanta’s next-generation protease inhibitor for hepatitis C virus (HCV) being developed in Enanta’s collaboration with AbbVie.
Contract Research & Services > Contract Services > News
DKSH to offer market expansion services for Roche's products across Asia
By PBR Staff Writer
DKSH Business Unit Healthcare has extended its relationship to offer market expansion services for Roche's full pharmaceutical product portfolio in Cambodia, Hong Kong, Laos, Malaysia, Myanmar, Singapore, Thailand and Vietnam.
Contract Research & Services > Contract Services > News
Batu Biologics gets license from California University for cancer drug
Batu Biologics, an immunotherapy company developing an anti-angiogenic cancer vaccine, announced the signing of a license agreement with the Regents of the University of California, granting exclusive rights to novel peptide drugs developed at UC San Diego that have been proven to stimulate cancer-killing immune responses.
Contract Research & Services > Contract Services > News
Selecta, JDRF and Sanofi to develop SVP immunotherapy for type 1 diabetes
By PBR Staff Writer
Selecta Biosciences and JDRF have extended their joint research collaboration and added Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP) immunotherapy for the treatment and prevention of the underlying cause of type 1 diabetes.
Contract Research & Services > Contract Services > News
Sucampo extends license, collaboration agreement with Takeda for Amitiza
By PBR Staff Writer
US-based Sucampo Pharmaceuticals has signed an amendment to the existing collaboration and license agreement with Takeda Pharmaceutical Company (Takeda) covering the US and Canada for Amitiza (lubiprostone).
Contract Research & Services > Contract Services > News
Hikma to distribute Eisai's epilepsy treatment Fycompa in Middle East
By PBR Staff Writer
UK-based Hikma Pharmaceuticals has entered into a five-year partnership to distribute Eisai’s first-in-class epilepsy treatment, Fycompa (perampanel), in the Middle East.
Contract Research & Services > Contract Services > News
Isis earns $18m milestone payment from GSK for advancing ISIS-TTR
By PBR Staff Writer
Isis Pharmaceuticals has earned an $18m milestone payment from GlaxoSmithKline (GSK) for the advancement of Phase II/III study of ISIS-TTR in patients with familial amyloid polyneuropathy (FAP).
Contract Research & Services > Contract Services > News
Nicox selects OptiMed as distributor in Australia and New Zealand
By PBR Staff Writer
Nicox has expanded its international distribution network by signing a deal with Australian firm OptiMed to distribute its AdenoPlus and the Xailin range in Australia and New Zealand.
Contract Research & Services > Contract Services > News
Dilafor, Opocrin sign supply and partnership deal for tafoxiparin
By PBR Staff Writer
Swedish drug development firm Dilafor has entered into a commercial supply and partnership agreement with Italy-based Opocrin for its polysaccharide derivative, tafoxiparin drug candidate.
Contract Research & Services > Contract Services > News
3R PHARMA CONSULTING - Reducing Regulatory Risk
3R PHARMA CONSULTING provides cost-effective, timely solutions to registration filings and challenges in pharmaceutical development strategies across Europe, the US and the rest of world.
Contract Research & Services > Contract Services > Suppliers
View all Contract Services news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250